CBD is a natural constituent of the hemp plant and is derived from hemp stalk and seed (same genus Cannabis Sativa as medical cannabis, but with no THC or psychoactive effect).
Scientific and clinical studies underscore CBD’s potential as a treatment for a wide range of conditions including arthritis, diabetes, MS, chronic pain, schizophrenia, PTSD, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrated neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere.
1000’s Of Clinical Studies
CBD works as the switch that turns on the regulatory system in the body called the endocannabinoid system. Your body produces its own cannabinoids. These endogenous cannabinoids are a part of a system that acts as the “master control” of the body, and this endocannabinoid system has naturally occurring cannabinoids and cannabinoid receptor sites throughout your entire body. CBD signals the body’s natural endogenous cannabinoids to activate those receptors to do more of what they normally do.
Below is a list of conditions treated by CBD:
Prion/Mad Cow disease
Spinal cord injury
The International Cannabinoid Research Society (ICRS)demonstrated CBD exerts a therapeutic impact. A preclinical study by Dr. Sean McAllister at the California Pacific Medical Center reports on how CBD kills breast cancer by down-regulating a gene called ID-1, which is implicated in several types of aggressive cancer. “Cannabidiol offers hope of a non-toxic therapy that could treat aggressive forms of cancer without any of the painful side effects of chemotherapy,” says McAllister.
CBD Chemical Structure
The images above are from an experiment by McAllister testing how CBD can stop the invasion of cancer cells in human cell lines. Compare the untreated breast cancer cells on the left to the breast cancer cells destroyed by CBD on the right.
Further Cancer Research
Cannabis Science, a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, reports on a recent press release by the San Francisco NBC news, with new studies by Scientists at California Pacific Medical Center, which have shown that cannabidiol, (CBD), has the ability to “turn off” a gene that causes breast and other types of cancers to metastasize, according to the San Francisco Chronicle newspaper.
NBC News reports, “The drug” has been shown to reduce pain and nausea” in cancer patients. AIDS patients also use cannabis to eat, sleep and otherwise be more functional. The researchers hope to move to clinical trials on humans soon to test the cannabidiol inhibition of metastasis, reported in the San Francisco Chronicle. “What they found is that the cannabinoid turns off the overexpression of ID-1, which makes the cells lose their ability to travel to distant tissues. In other words, it keeps the cells more local and blocks their ability to metastasize. (spread to a new location).